These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 36581934

  • 1. Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
    Ripping TM, Rammant E, Witjes JA, Aaronson NK, van Hemelrijck M, van Hoogstraten LMC, BlaZIB study group, Kiemeney LA, Aben KKH.
    Health Qual Life Outcomes; 2022 Dec 29; 20(1):171. PubMed ID: 36581934
    [Abstract] [Full Text] [Related]

  • 2. Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer.
    Ripping TM, Westhoff E, Aaronson NK, Van Hemelrijck M, Rammant E, Witjes JA, Kiemeney LA, Aben KKH, Vrieling A.
    J Patient Rep Outcomes; 2021 Sep 20; 5(1):96. PubMed ID: 34542736
    [Abstract] [Full Text] [Related]

  • 3. Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer.
    Blazeby JM, Hall E, Aaronson NK, Lloyd L, Waters R, Kelly JD, Fayers P.
    Eur Urol; 2014 Dec 20; 66(6):1148-56. PubMed ID: 24612661
    [Abstract] [Full Text] [Related]

  • 4. Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24.
    Park J, Shin DW, Kim TH, Jung SI, Nam JK, Park SC, Hong S, Jung JH, Kim H, Kim WT.
    Cancer Res Treat; 2018 Jan 20; 50(1):40-49. PubMed ID: 28279061
    [Abstract] [Full Text] [Related]

  • 5. The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review.
    Rammant E, Fox L, Beyer K, Aaronson NK, Chaloner R, De Padova S, Liedberg F, Wintner LM, Decaestecker K, Fonteyne V, Perdek N, Wylie H, Catto JWF, Ripping TM, Holzner B, Van Leeuwen M, Van Hemelrijck M, EORTC Quality of Life Group.
    Qual Life Res; 2023 Aug 20; 32(8):2127-2135. PubMed ID: 36648569
    [Abstract] [Full Text] [Related]

  • 6. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
    Sztankay M, Aaronson NK, Arraras JI, Basso U, Bumbasirevic U, Efficace F, Giesinger JM, Johnson CD, van Leeuwen M, Oberguggenberger AS, Sosnowski R, Young T, Holzner B, European Organisation for Research and Treatment of Cancer Quality of Life Group (EORTC QLG).
    BMC Cancer; 2018 Nov 12; 18(1):1104. PubMed ID: 30419889
    [Abstract] [Full Text] [Related]

  • 7. An international field study for the reliability and validity of the EORTC communication questionnaire EORTC QLQ-COMU26.
    Arraras JI, Giesinger J, Shamieh O, Bahar I, Koller M, Bredart A, Costantini A, Greimel E, Sztankay M, Wintner LM, de Sousa MC, Ishiki H, Kontogianni M, Wolan M, Kikawa Y, Lanceley A, Gioulbasanis I, Harle A, Zarandona U, Kulis D, Kuljanic K, European Organisation for Research, Treatment of Cancer (EORTC) Quality of Life Group.
    Health Qual Life Outcomes; 2024 Oct 10; 22(1):87. PubMed ID: 39385305
    [Abstract] [Full Text] [Related]

  • 8. Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka.
    Kosgallana S, Jayasekara P, Abeysinghe P, Hjermstad M, Lalloo R.
    BMC Oral Health; 2022 Aug 19; 22(1):359. PubMed ID: 35986341
    [Abstract] [Full Text] [Related]

  • 9. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Araya LT, Gebretekle GB, Gebremariam GT, Fenta TG.
    Health Qual Life Outcomes; 2019 Jan 14; 17(1):13. PubMed ID: 30642359
    [Abstract] [Full Text] [Related]

  • 10. Psychometric properties of the Urdu version of the EORTC QLQ-H&N35 (European organization for research and treatment of cancer head and neck module) quality of life tool.
    Zahid N, Martins RS, Zahid W, Azam I, Ikram M, Hassan A, Bhamani SS, Jabbar AA, Asad N, Akhtar S, Siddiqui MI, Awan MS, Ahmad K.
    BMC Psychol; 2022 Aug 07; 10(1):194. PubMed ID: 35934706
    [Abstract] [Full Text] [Related]

  • 11. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
    Koller M, Shamieh O, Hjermstad MJ, Hornslien K, Young T, Chalk T, Ioannidis G, Harle A, Johnson CD, Tomaszewski KA, Serpentini S, Pinto M, van der Weijst L, Janssens A, Morag O, Chie WC, Arraras JI, Pompili C, Jungraithmayr W, Hechtner M, Katsochi D, Müller K, Gräfenstein L, Schulz C, Bottomley A, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group, EORTC Lung Cancer Group, European Society of Thoracic Surgeons.
    Lancet Oncol; 2020 May 07; 21(5):723-732. PubMed ID: 32213338
    [Abstract] [Full Text] [Related]

  • 12. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
    Oerlemans S, Efficace F, Kyriakou C, Freitas AC, Shamieh O, Creutzberg CL, Lehmann J, Petranovic D, Nagele E, Bredart A, Dong D, Scholz CW, Caocci G, Molica S, Griskevicius L, Xochelli A, Kieffer JM, Agelink van Rentergem JA, Alrjoub W, Mueller A, Gomes Da Silva M, Alves da Costa F, Malak S, Cocks K, van de Poll-Franse LV, EORTC Quality of Life Group.
    Cancer; 2023 Sep 01; 129(17):2727-2740. PubMed ID: 37204189
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reliability and Validity of Amharic Version of EORTC QLQ-C 30 Questionnaire among Gynecological Cancer Patients in Ethiopia.
    Ayana BA, Negash S, Yusuf L, Tigeneh W, Haile D.
    PLoS One; 2016 Sep 01; 11(6):e0157359. PubMed ID: 27304066
    [Abstract] [Full Text] [Related]

  • 15. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran.
    Khoshnevisan A, Yekaninejad MS, Ardakani SK, Pakpour AH, Mardani A, Aaronson NK.
    Health Qual Life Outcomes; 2012 May 20; 10():54. PubMed ID: 22607028
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. International Phase IV Field Study for the Reliability and Validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34.
    Singer S, Al-Ibraheem A, Pinto M, Iakovou I, Østhus AA, Hammerlid E, Locati LD, Gamper E, Ignacio J, Jordan SJ, Kiyota N, Buettner M, Engesser D, Canotilho R, Ioannidis G, Husson O, Gama RR, Fanetti G, Moss L, Inhestern J, Andry G, Fuehrer D, Kuliś D, Rimmele H, Sykiotis G.
    Thyroid; 2023 Sep 20; 33(9):1078-1089. PubMed ID: 37450344
    [Abstract] [Full Text] [Related]

  • 18. Assessing the acceptability, reliability, and validity of the EORTC Quality of Life Questionnaire (QLQ-C30) in Kenyan cancer patients: a cross-sectional study.
    Davda J, Kibet H, Achieng E, Atundo L, Komen T.
    J Patient Rep Outcomes; 2021 Jan 07; 5(1):4. PubMed ID: 33415528
    [Abstract] [Full Text] [Related]

  • 19. International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction.
    Winters ZE, Afzal M, Rutherford C, Holzner B, Rumpold G, da Costa Vieira RA, Hartup S, Flitcroft K, Bjelic-Radisic V, Oberguggenberger A, Panouilleres M, Mani M, Catanuto G, Douek M, Kokan J, Sinai P, King MT, European Organisation for Research and Treatment of Cancer Quality of Life Group.
    Br J Surg; 2018 Feb 07; 105(3):209-222. PubMed ID: 29116657
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.